Cargando…
Beyond Ipilimumab: a review of immunotherapeutic approaches in clinical trials in melanoma
In this first in a series of ‘Trials Watch’ articles, we briefly review a highly selected set of clinical trials that are currently recruiting or about to open to recruitment in melanoma, the disease first transformed by the introduction of immune checkpoint blockade inhibitors (ICI). We place equal...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585671/ https://www.ncbi.nlm.nih.gov/pubmed/36284898 http://dx.doi.org/10.1093/immadv/ltaa010 |